Novel bladder cancer treatment gains MHRA approval in the UK

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment of adults with unresectable or metastatic urothelial carcinoma (UC), the most common form of bladder cancer.

Pα+: A Nue Lease of Life? Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health – Psychedelic Alpha

Late last month, psychedelic venture studio Beckley Waves announced that it had acquired Nue Life, an at-home ketamine provider. (Nue Life was acquired by NueCo

November 10, 2023

‘Realistic Chance for Pregnancy’ After Stem Cell Transplant, German Study Suggests

While women who undergo allogeneic hematopoietic cell transplantation (alloHCT) face significant treatment-related challenges regarding fertility, successful pregnancies are possible, according to results from a retrospective

July 20, 2024

Judge Rules Against Stem Cell Clinic

A federal court has once again ruled against a stem cell clinic, siding with the FDA that fat-derived stem cell treatments are a “drug” and

October 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.